On June 19, 2018, plaintiffs filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally-filed lawsuits concerning the Zimmer M/L Taper with Kinectiv Technology and VerSys femoral head hip replacement products. Plaintiffs claim that the components are defectively designed…
We’re featuring Karen Beyea-Schroeder of Schroeder Law Office PLLC in The Woodlands, TX.
The U.S. Food and Drug Administration (FDA) offers three ways to safely dispose of unneeded medications.
The Supreme Court of Nebraska reviews Gimple v. Student Transp. Of America, which involved Shelley R. Gimple and the Student Transportation of America and National Interstate Ins. Co. A drunk driver recklessly drove a vehicle that crashed into a school bus driven by Shelly R.…
The Pennsylvania grand jury released a report last Tuesday detailing decades worth of sexual misconduct in six of its eight Roman Catholic dioceses. Despite the 900-pages worth of report, so much was not included with the absence of unrecorded cases, redactions, and information too lengthy or complex to…
The Food and Drug Administration (FDA) recently warned that neurovascular stents used to help treat certain unruptured aneurysms could cause serious and sometimes deadly side effects. The administration has received reports of some patients who have received these stents and then suffered a stroke and/or…
On July 13, 2018, the FDA announced a voluntary recall of medications containing “valsartan,” a high-blood-pressure drug that was found to be contaminated with an impurity classified as a possible carcinogen. Not all drugs were recalled—only those containing valsartan supplied by Zhejiang Huahai Pharmaceuticals from…